NCT06635174

Brief Summary

The aim of this study is to determine the effect of 50% oral dextrose in reducing pain before Bladder Catheterization. This study will answer the following question Is there any effect of 50% dextrose in reducing pain response to infants from age 1-90 days undergoing bladder catheterization during their visit in emergency department it is double blind randomized control trial comparing 2ml 50% dextrose as oral solution with placebo 2ml of normal water Primary Objective \- To evaluate the impact of administrating oral glucose on pain control compared with placebo in blood pressure , Heart rate, respiratory rate and oxygen saturation before and after the procedure Secondary Objectives

  • To compare random blood sugar before and after the procedure
  • To compare the incident and the duration of crying in both groups administration of oral solution 2ml of solutions to be administered orally as drops at tip of the tongue after that will wait for 2 minutes before the procedure start , after 2 minutes from the oral solution , the procedure will start

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

October 9, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 10, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

October 10, 2024

Status Verified

October 1, 2024

Enrollment Period

5 months

First QC Date

October 3, 2024

Last Update Submit

October 9, 2024

Conditions

Keywords

50% dextroseneonatal pain management

Outcome Measures

Primary Outcomes (4)

  • change in blood pressure

    blood pressure will be measured before the procedure and 3 minutes, 5 minutes and 7 minutes after oral solution administration. each vital will be analyzed as single variable comparing it with the baseline. for example (baseline blood pressure will be compared with the blood pressure during procedure after oral solution) the different of both blood pressure will be analyzed whiter there is significant change or not in both group

    3 minutes, 5 minutes and 7 minutes after oral solution will be administrated

  • change in The Neonatal Infant Pain Scale (NIPS)

    the Neonatal Infant Pain Scale (NIPS) will be calculated by trained treating nurse staff 3 minutes, 5 minutes and 7 minutes after administration of oral solution

    3 minutes, 5 minutes and 7 minutes after administration of oral solution

  • change in the heart rate

    heart rate will be measured before the procedure and 3 minutes, 5 minutes and 7 minutes after oral solution administration. each vital will be analyzed as single variable comparing it with the baseline. for example (baseline heart rate will be compared with the heart rate during procedure after oral solution) the different of both heart rate will be analyzed whiter there is significant change or not in both group

    3 minutes, 5 minutes and 7 minutes after oral solution administration.

  • change in respiratory rate

    respiratory rate will be measured before the procedure and 3 minutes, 5 minutes and 7 minutes after oral solution administration. each vital will be analyzed as single variable comparing it with the baseline. for example (baseline respiratory rate will be compared with the respiratory rate during procedure after oral solution) the different of both heart rate will be analyzed whiter there is significant change or not in both group

    3 minutes, 5 minutes and 7 minutes after oral solution administration.

Secondary Outcomes (3)

  • random blood sugar

    10 minutes

  • the duration of crying in placebo group

    10 minutes

  • the duration of crying in dextrose group

    10 minutes

Study Arms (2)

control group

PLACEBO COMPARATOR

in this arm participant will receive oral 2ml of normal water

Other: normal water

50% dextrose group

EXPERIMENTAL

this arm will include the participant who will receive 50% oral dextrose

Other: Dextrose

Interventions

we are using 2ml of 50% dextrose

50% dextrose group

patient will receive 2ml of normal water

control group

Eligibility Criteria

Age1 Day - 90 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age from 1 day to 90 days
  • Did not received analgesia for last 6 hours

You may not qualify if:

  • Preterm newborns presenting in ED younger than 38 weeks (corrected age)
  • Unstable child
  • Suspicion of enterocolitis
  • Esophageal- tracheal fistula not operated
  • Known case of fructose intolerance
  • Oral congenital malformation (cleft palate)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ali Al Qubtan

Muscat, Muḩāfaz̧at Masqaţ, 100, Oman

Location

Related Links

MeSH Terms

Conditions

Agnosia

Interventions

Glucose

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Randomization will be generated at the local pharmacy by a computer program in blocks of two and the randomization allotment only will be known by a pharmacist not involved in the care of the children. after that the pharmacist will prepper the syringe than contain the 2ml 50% dextrose or the placebo 2ml normal water. each syringe will have code. the code key will be only with the pharmacist.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Total of 90 patient divided randomly in 2 groups, one group will receive 2ml of 50% oral dextrose and control group will receive 2ml of normal water as placebo. The Neonatal Infant Pain Scale (NIPS) will be used to measure the pain score among the infants. It was designed and validated in Canada by Lawrence J Alcock D et al. It uses the behaviors that nurses have described as being indicative of infant pain or distress. It is composed of six (6) Parameters Facial expression Cry Breathing patterns Arms Legs State of arousal
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
emergency resident

Study Record Dates

First Submitted

October 3, 2024

First Posted

October 10, 2024

Study Start

October 9, 2024

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

October 10, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

Data obtained through this study may be provided to qualified researchers with academic interest in randomized control trials. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis
Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).

Locations